Stefano Di Bernardo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stefano Di Bernardo has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- Marie-Hélène Perez
Pediatric Intensive and Intermediate Care Units, Women-Mother Child Department, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
8 shared publications - Nicole Sekarski
Paediatric Cardiology Unit, Women-Mother-Child Department, Lausanne University Hospital, University of Lausanne, 1005 Lausanne, Switzerland
5 shared publications Michel Hurni
Department of Cardiac Surgery, University Hospital of Vaud, Lausanne, Switzerland
4 shared publicationsNicole Sekarski
4 shared publications- Yvan Mivelaz
Paediatric Cardiology Unit, Woman-Mother-Child Department, Lausanne University Hospital (CHUV), Lausanne, Switzerland
4 shared publications - Arnaud Chiolero
Population Health Laboratory (#PopHealthLab), University of Fribourg , Fribourg
3 shared publications
Latest Publications
- Open Access
- 7 May 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (6) , 361
Outpatient drug therapy for children with heart disease in Switzerland: a survey
Cardiovascular drug therapy in adults is steadily progressing. However, the extent to which children with heart disease in Switzerland benefit from this progress remains unknown. This survey aimed to investigate the current outpatient prescribing practices among paediatric cardiologists in Switzerland. We conducted a cross-sectional survey among Swiss paediatric cardiologists. The physicians were asked to state how often they administer drugs on a pre-defined list for the following indications: heart failure, arrhythmia and thromboembolism. Forty-three (56%) out of 77 eligible physicians completed the survey. For paediatric heart failure, the three most frequently prescribed drugs were hydrochlorothiazide (‘often prescribed’ by n = 25, 58%), lisinopril (n = 24, 56%), and spironolactone (n = 32, 74%). The most frequently prescribed drugs for arrhythmia and thromboembolism were propranolol (n = 26, 60%) and acetylsalicylic acid (n = 31, 72%), respectively. Newer drugs such as sacubitril/valsartan (‘never prescribed’ by n = 20, 47%), sodium-glucose cotransporter type 2 inhibitors (n = 40, 93%), and direct oral anticoagulants (n = 20, 47%) were rarely used. Conclusion: The drugs used to treat heart failure, arrhythmia, and thromboembolism in Switzerland largely reflect current international recommendations. Nevertheless, novel drugs are rarely used. In addition to the lack of large randomized controlled drug trials in children, important obstacles are lack of authorization, lack of reimbursement, and lack of suitable formulations. These issues should be addressed by both the industry and healthcare providers to continuously improve drug therapy for children with heart disease. What is Known: • Evidence for drug use in Paediatric cardiology mostly relies on extrapolation from adult studies and pathophysiological considerations. • Drug choices are also influenced by drug approval, insurance reimbursement, and availability of age-appropriate formulations. What is New: • Swiss paediatric cardiologists predominantly rely on established drugs to treat cardiovascular diseases in children, with the use of newer drugs remaining limited. • On top of expert consensus, adult evidence, and drug availability, drug prescription appears to be strongly influenced by the availability of child-friendly formulations.
- 7 May 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (6) , 361
Open AccessOutpatient drug therapy for children with heart disease in Switzerland: a survey
Cardiovascular drug therapy in adults is steadily progressing. However, the extent to which children with heart disease in Switzerland benefit from this progress remains unknown. This survey aimed to investigate the current outpatient prescribing practices among paediatric cardiologists in Switzerland. We conducted a cross-sectional survey among Swiss paediatric cardiologists. The physicians were asked to state how often they administer drugs on a pre-defined list for the following indications: heart failure, arrhythmia and thromboembolism. Forty-three (56%) out of 77 eligible physicians completed the survey. For paediatric heart failure, the three most frequently prescribed drugs were hydrochlorothiazide (‘often prescribed’ by n = 25, 58%), lisinopril (n = 24, 56%), and spironolactone (n = 32, 74%). The most frequently prescribed drugs for arrhythmia and thromboembolism were propranolol (n = 26, 60%) and acetylsalicylic acid (n = 31, 72%), respectively. Newer drugs such as sacubitril/valsartan (‘never prescribed’ by n = 20, 47%), sodium-glucose cotransporter type 2 inhibitors (n = 40, 93%), and direct oral anticoagulants (n = 20, 47%) were rarely used. Conclusion: The drugs used to treat heart failure, arrhythmia, and thromboembolism in Switzerland largely reflect current international recommendations. Nevertheless, novel drugs are rarely used. In addition to the lack of large randomized controlled drug trials in children, important obstacles are lack of authorization, lack of reimbursement, and lack of suitable formulations. These issues should be addressed by both the industry and healthcare providers to continuously improve drug therapy for children with heart disease. What is Known: • Evidence for drug use in Paediatric cardiology mostly relies on extrapolation from adult studies and pathophysiological considerations. • Drug choices are also influenced by drug approval, insurance reimbursement, and availability of age-appropriate formulations. What is New: • Swiss paediatric cardiologists predominantly rely on established drugs to treat cardiovascular diseases in children, with the use of newer drugs remaining limited. • On top of expert consensus, adult evidence, and drug availability, drug prescription appears to be strongly influenced by the availability of child-friendly formulations.
- Open Access
- 22 March 2026
- Published by MDPI AG in Clinics and Practice
- Vol. 16 (3) , 63
Preoperative Administration of Levosimendan to Prevent Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery: A Retrospective Study
Background: Low cardiac output syndrome (LCOS) is a significant cause of postoperative morbidity and mortality in children with congenital heart disease. Prophylactic levosimendan is increasingly used to prevent LCOS, but its superiority to other strategies remains unproven. Based on the pharmacokinetics of levosimendan, we hypothesize that preoperative administration is beneficial for preventing LCOS in a specifically at-risk population. Methods: This is a retrospective single-center cohort study in a tertiary pediatric intensive care unit. All patients under one year of age undergoing surgery for congenital heart disease using cardiopulmonary bypass and receiving levosimendan within 24 h before or after surgery were included and classified into two groups: preoperative and postoperative administration. Results: Overall, 107 patients were included. Fifty-three patients (49.5%) received levosimendan before surgery, with significantly lower mortality, fewer LCOS markers, and lower LCOS scores compared to patients receiving levosimendan after surgery. Although not significant, the use of extracorporeal membrane oxygenation, renal replacement therapy, and temperature control was also lower in the preoperative group. There was no difference in mechanical ventilation duration and length of stay. Conclusions: Preoperative administration of levosimendan seems associated with a lower incidence of LCOS and reduced mortality in high-risk children with congenital heart surgery.
- 22 March 2026
- Published by MDPI AG in Clinics and Practice
- Vol. 16 (3) , 63
Open AccessPreoperative Administration of Levosimendan to Prevent Low Cardiac Output Syndrome Following Pediatric Cardiac Surgery: A Retrospective Study
Background: Low cardiac output syndrome (LCOS) is a significant cause of postoperative morbidity and mortality in children with congenital heart disease. Prophylactic levosimendan is increasingly used to prevent LCOS, but its superiority to other strategies remains unproven. Based on the pharmacokinetics of levosimendan, we hypothesize that preoperative administration is beneficial for preventing LCOS in a specifically at-risk population. Methods: This is a retrospective single-center cohort study in a tertiary pediatric intensive care unit. All patients under one year of age undergoing surgery for congenital heart disease using cardiopulmonary bypass and receiving levosimendan within 24 h before or after surgery were included and classified into two groups: preoperative and postoperative administration. Results: Overall, 107 patients were included. Fifty-three patients (49.5%) received levosimendan before surgery, with significantly lower mortality, fewer LCOS markers, and lower LCOS scores compared to patients receiving levosimendan after surgery. Although not significant, the use of extracorporeal membrane oxygenation, renal replacement therapy, and temperature control was also lower in the preoperative group. There was no difference in mechanical ventilation duration and length of stay. Conclusions: Preoperative administration of levosimendan seems associated with a lower incidence of LCOS and reduced mortality in high-risk children with congenital heart surgery.
- Open Access
- 1 July 2025
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1599311
Editorial: Management of congenital heart disease: challenges, implications, innovations and pitfalls
Congenital heart disease (CHD)poses one of the most complex challenges in modern medicine. Impacting numerous people worldwide, it affects individuals from fetal development through adulthood, necessitating precise diagnosis along with personalized and adaptive treatment strategies. Congenital heart disease care is rapidly evolving, driven by advancements in molecular biology, imaging technologies, intervention techniques, and patient monitoring. This research topic features eight contributions that highlight this evolution. Instead of presenting these advancements in isolation, I aimed to connect these works and create a compelling narrative for the future management of CHD.________________________________________From rare mutations to physiological adaptation: refining our understandingGenetic and developmental biology advancements are crucial to decoding the diverse phenotypes seen in CHD. In a striking case report, Sun et al. describe a restrictive cardiomyopathy caused by a rare TNNI3 mutation (https://doi.org/10.3389/fcvm.2024.1456542), highlighting the diagnostic synergy of cardiac MRI and next-generation sequencing. Such reports underscore the power of personalized molecular insights to guide management in unexplained or severe presentations.Physiological adaptation is another dimension of complexity in CHD. In their systematic review and meta-analysis, Moyon et al. (https://doi.org/10.3389/fcvm.2024.1493698) explore how patients with CHD perform during cardiopulmonary exercise testing at high altitudes. Their findings demonstrate a significantly reduced exercise capacity compared to sea-level peers — a reminder that geography and oxygen availability are hidden yet potent modifiers of clinical outcomes.Similarly, Wiedemann et al. (https://doi.org/10.3389/fped.2024.1443924) describe electromechanical dyssynchrony of the right ventricle after tetralogy of Fallot repair in infants. This finding has implications for long-term surveillance and may influence postoperative pacing strategies or imaging follow-up.Improving interventions: toward less invasive and more patient-centered careIn CHD, interventions are often staged and technically complex. However, they are also rapidly evolving. Prakoso et al. (https://doi.org/10.3389/fcvm.2024.1382879) compare ductal stenting to surgical shunting in patients with late-presenting, duct-dependent pulmonary circulation. Their results — showing reduced hospital stays and similar mortality — reinforce the potential of catheter-based approaches even in traditionally reserved surgery settings.Building on this, Rosenthal et al. (https://doi.org/10.3389/fped.2024.1436608) report on an application-based interstage home monitoring (IHM) program for infants with shunt- or duct-dependent pulmonary perfusion. Their success in reducing interstage mortality through digital tools speaks to a future where connected care and parental empowerment become cornerstones of CHD management.Meanwhile, Ahmed et al. (https://doi.org/10.3389/fcvm.2024.1368921) provide a two-decade retrospective analysis of pulmonary artery banding in a tertiary center. Their insights into indications, outcomes, and complications help refine our understanding of this palliative approach, particularly in low-resource or high-complexity contexts.Connecting metabolism, anatomy, and imaging: toward precision monitoringMetabolomics is a growing field with immense potential in pediatric cardiac care. Walsh et al. (https://doi.org/10.3389/fcvm.2024.1491046) review the existing literature on metabolomic profiles in infants undergoing cardiopulmonary bypass, linking metabolic patterns to outcomes like acute kidney injury and neurologic complications. These emerging biomarkers may enable real-time risk stratification and individualized organ protection strategies.Anatomic variation also plays a pivotal role in outcomes. In their report of two cases and a literature review, Wu et al. (https://doi.org/10.3389/fcvm.2024.1454680) detail anomalous pulmonary venous return due to septum primum malposition — a subtle but significant lesion. Their findings advocate for meticulous echocardiographic assessment in infants with unexplained desaturation or right-sided volume overload.ConclusionThese eight contributions collectively reflect the breadth and depth of current advances in congenital heart disease. Each article reinforces the need for an integrated, patient-centered approach, from molecular diagnosis to long-term functional outcomes and surgical technique to digital follow-up. As CHD care evolves, such multidisciplinary insights will be essential to building a future of truly individualized and adaptive medicine.
- 1 July 2025
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 13, 1599311
Open AccessEditorial: Management of congenital heart disease: challenges, implications, innovations and pitfalls
Congenital heart disease (CHD)poses one of the most complex challenges in modern medicine. Impacting numerous people worldwide, it affects individuals from fetal development through adulthood, necessitating precise diagnosis along with personalized and adaptive treatment strategies. Congenital heart disease care is rapidly evolving, driven by advancements in molecular biology, imaging technologies, intervention techniques, and patient monitoring. This research topic features eight contributions that highlight this evolution. Instead of presenting these advancements in isolation, I aimed to connect these works and create a compelling narrative for the future management of CHD.________________________________________From rare mutations to physiological adaptation: refining our understandingGenetic and developmental biology advancements are crucial to decoding the diverse phenotypes seen in CHD. In a striking case report, Sun et al. describe a restrictive cardiomyopathy caused by a rare TNNI3 mutation (https://doi.org/10.3389/fcvm.2024.1456542), highlighting the diagnostic synergy of cardiac MRI and next-generation sequencing. Such reports underscore the power of personalized molecular insights to guide management in unexplained or severe presentations.Physiological adaptation is another dimension of complexity in CHD. In their systematic review and meta-analysis, Moyon et al. (https://doi.org/10.3389/fcvm.2024.1493698) explore how patients with CHD perform during cardiopulmonary exercise testing at high altitudes. Their findings demonstrate a significantly reduced exercise capacity compared to sea-level peers — a reminder that geography and oxygen availability are hidden yet potent modifiers of clinical outcomes.Similarly, Wiedemann et al. (https://doi.org/10.3389/fped.2024.1443924) describe electromechanical dyssynchrony of the right ventricle after tetralogy of Fallot repair in infants. This finding has implications for long-term surveillance and may influence postoperative pacing strategies or imaging follow-up.Improving interventions: toward less invasive and more patient-centered careIn CHD, interventions are often staged and technically complex. However, they are also rapidly evolving. Prakoso et al. (https://doi.org/10.3389/fcvm.2024.1382879) compare ductal stenting to surgical shunting in patients with late-presenting, duct-dependent pulmonary circulation. Their results — showing reduced hospital stays and similar mortality — reinforce the potential of catheter-based approaches even in traditionally reserved surgery settings.Building on this, Rosenthal et al. (https://doi.org/10.3389/fped.2024.1436608) report on an application-based interstage home monitoring (IHM) program for infants with shunt- or duct-dependent pulmonary perfusion. Their success in reducing interstage mortality through digital tools speaks to a future where connected care and parental empowerment become cornerstones of CHD management.Meanwhile, Ahmed et al. (https://doi.org/10.3389/fcvm.2024.1368921) provide a two-decade retrospective analysis of pulmonary artery banding in a tertiary center. Their insights into indications, outcomes, and complications help refine our understanding of this palliative approach, particularly in low-resource or high-complexity contexts.Connecting metabolism, anatomy, and imaging: toward precision monitoringMetabolomics is a growing field with immense potential in pediatric cardiac care. Walsh et al. (https://doi.org/10.3389/fcvm.2024.1491046) review the existing literature on metabolomic profiles in infants undergoing cardiopulmonary bypass, linking metabolic patterns to outcomes like acute kidney injury and neurologic complications. These emerging biomarkers may enable real-time risk stratification and individualized organ protection strategies.Anatomic variation also plays a pivotal role in outcomes. In their report of two cases and a literature review, Wu et al. (https://doi.org/10.3389/fcvm.2024.1454680) detail anomalous pulmonary venous return due to septum primum malposition — a subtle but significant lesion. Their findings advocate for meticulous echocardiographic assessment in infants with unexplained desaturation or right-sided volume overload.ConclusionThese eight contributions collectively reflect the breadth and depth of current advances in congenital heart disease. Each article reinforces the need for an integrated, patient-centered approach, from molecular diagnosis to long-term functional outcomes and surgical technique to digital follow-up. As CHD care evolves, such multidisciplinary insights will be essential to building a future of truly individualized and adaptive medicine.
- Open Access
- 1 September 2024
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 154 (9) , 3575
Use of ultrasound for vascular access during cardiac catheterisation in children with congenital heart disease: a Swiss multicentre cohort study
AIM OF THE STUDY: Our study aimed to assess the first-attempt success rate of ultrasound (US) and anatomical landmark (ALM) guidance for vascular cannulation in children with congenital heart disease in Switzerland. METHODS: A prospective observational multicentre study was conducted from January 2022 to January 2023 in three university hospitals in Switzerland. We included patients with congenital heart disease aged 0 to 18 years who were scheduled for elective cardiac catheterisation. Periprocedural data were collected anonymously. The choice of vessel and guidance technique were at the operator’s discretion. RESULTS: 177 arterial and 240 venous cannulations in 253 patients were analysed. The median age and weight were 4.4 years (interquartile range [IQR] 1.2–8.8) and 15 kg (IQR 8–27), respectively. Nearly all operators, 97.5%, were deemed experienced. The femoral artery and femoral vein were the most preferred vessels. US guidance was used in 62% of procedures, predominantly within populations who were younger, smaller and of lower weight.The success rate at the first attempt was notably higher with US guidance for arterial cannulation (US: 80%, ALM: 37%, p <0.001) and venous cannulation (US: 78% vs ALM: 47%, p <0.001). Overall success rates for venous and arterial cannulation were comparable between ultrasound and anatomical landmark guidance. A total of 45 complications (10.5%) occurred, with immediate uncomplicated haematoma being the most frequent. CONCLUSION: US guidance is preferred for the localisation and cannulation of vessels during cardiac catheterisation within paediatric cardiology departments in Switzerland. Given its high success rate for first-attempt cannulation, US warrants additional research to evaluate its potential in reducing complications.
- 1 September 2024
- Published by SMW Supporting Association in Swiss Medical Weekly
- Vol. 154 (9) , 3575
Open AccessUse of ultrasound for vascular access during cardiac catheterisation in children with congenital heart disease: a Swiss multicentre cohort study
AIM OF THE STUDY: Our study aimed to assess the first-attempt success rate of ultrasound (US) and anatomical landmark (ALM) guidance for vascular cannulation in children with congenital heart disease in Switzerland. METHODS: A prospective observational multicentre study was conducted from January 2022 to January 2023 in three university hospitals in Switzerland. We included patients with congenital heart disease aged 0 to 18 years who were scheduled for elective cardiac catheterisation. Periprocedural data were collected anonymously. The choice of vessel and guidance technique were at the operator’s discretion. RESULTS: 177 arterial and 240 venous cannulations in 253 patients were analysed. The median age and weight were 4.4 years (interquartile range [IQR] 1.2–8.8) and 15 kg (IQR 8–27), respectively. Nearly all operators, 97.5%, were deemed experienced. The femoral artery and femoral vein were the most preferred vessels. US guidance was used in 62% of procedures, predominantly within populations who were younger, smaller and of lower weight.The success rate at the first attempt was notably higher with US guidance for arterial cannulation (US: 80%, ALM: 37%, p <0.001) and venous cannulation (US: 78% vs ALM: 47%, p <0.001). Overall success rates for venous and arterial cannulation were comparable between ultrasound and anatomical landmark guidance. A total of 45 complications (10.5%) occurred, with immediate uncomplicated haematoma being the most frequent. CONCLUSION: US guidance is preferred for the localisation and cannulation of vessels during cardiac catheterisation within paediatric cardiology departments in Switzerland. Given its high success rate for first-attempt cannulation, US warrants additional research to evaluate its potential in reducing complications.
- Open Access
- 9 May 2024
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 183 (8) , 3309-3317
Early postoperative beta-blockers are associated with improved cardiac output after late complete repair of tetralogy of Fallot: a retrospective cohort study
Tetralogy of Fallot is the most common cyanotic congenital heart disease. For decades, our institution has cared for humanitarian patients with late presentation of tetralogy of Fallot. They are characterized by severe right ventricular hypertrophy with consecutive diastolic dysfunction, increasing the risk of postoperative low cardiac output syndrome (LCOS). By right ventricular restrictive physiology, we hypothesized that patients receiving early postoperative beta-blockers (within 48 h after cardiopulmonary bypass) may have better diastolic function and cardiac output. This is a retrospective cohort study in a single-center tertiary pediatric intensive care unit. We included > 1-year-old humanitarian patients with a confirmed diagnosis of tetralogy of Fallot undergoing a complete surgical repair between 2005 and 2019. We measured demographic data, preoperative echocardiographic and cardiac catheterization measures, postoperative mean heart rate, vasoactive-inotropic scores, LCOS scores, length of stay, and mechanical ventilation duration. One hundred sixty-five patients met the inclusion criteria. Fifty-nine patients (36%) received early postoperative beta-blockers, associated with a lower mean heart rate, higher vasoactive-inotropic scores, and lower LCOS scores during the first 48 h following cardiopulmonary bypass. There was no significant difference in lengths of stay and ventilation. Conclusion: Early postoperative beta-blockers lower the prevalence of postoperative LCOS at the expense of a higher need for vasoactive drugs without any consequence on length of stay and ventilation duration. This approach may benefit the specific population of children undergoing a late complete repair of tetralogy of Fallot. What is Known:• Prevalence of low cardiac output syndrome is high following a late complete surgical repair of tetralogy of Fallot. What is New:• Early postoperative beta-blockade is associated with lower heart rate, prolonged relaxation time, and lower prevalence of low cardiac output syndrome.• Negative chronotropic agents like beta-blockers may benefit selected patients undergoing a late complete repair of tetralogy of Fallot, who are numerous in low-income countries.
- 9 May 2024
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 183 (8) , 3309-3317
Open AccessEarly postoperative beta-blockers are associated with improved cardiac output after late complete repair of tetralogy of Fallot: a retrospective cohort study
Tetralogy of Fallot is the most common cyanotic congenital heart disease. For decades, our institution has cared for humanitarian patients with late presentation of tetralogy of Fallot. They are characterized by severe right ventricular hypertrophy with consecutive diastolic dysfunction, increasing the risk of postoperative low cardiac output syndrome (LCOS). By right ventricular restrictive physiology, we hypothesized that patients receiving early postoperative beta-blockers (within 48 h after cardiopulmonary bypass) may have better diastolic function and cardiac output. This is a retrospective cohort study in a single-center tertiary pediatric intensive care unit. We included > 1-year-old humanitarian patients with a confirmed diagnosis of tetralogy of Fallot undergoing a complete surgical repair between 2005 and 2019. We measured demographic data, preoperative echocardiographic and cardiac catheterization measures, postoperative mean heart rate, vasoactive-inotropic scores, LCOS scores, length of stay, and mechanical ventilation duration. One hundred sixty-five patients met the inclusion criteria. Fifty-nine patients (36%) received early postoperative beta-blockers, associated with a lower mean heart rate, higher vasoactive-inotropic scores, and lower LCOS scores during the first 48 h following cardiopulmonary bypass. There was no significant difference in lengths of stay and ventilation. Conclusion: Early postoperative beta-blockers lower the prevalence of postoperative LCOS at the expense of a higher need for vasoactive drugs without any consequence on length of stay and ventilation duration. This approach may benefit the specific population of children undergoing a late complete repair of tetralogy of Fallot. What is Known:• Prevalence of low cardiac output syndrome is high following a late complete surgical repair of tetralogy of Fallot. What is New:• Early postoperative beta-blockade is associated with lower heart rate, prolonged relaxation time, and lower prevalence of low cardiac output syndrome.• Negative chronotropic agents like beta-blockers may benefit selected patients undergoing a late complete repair of tetralogy of Fallot, who are numerous in low-income countries.
- Open Access
- 12 April 2024
- Published by ICR Publications LTD in Journal of Heart Valve Disease Innovation
- Vol. 29 (1) , 30-36
The Dilemma of Pulmonary Valve Replacement In Patients With Repaired Tetralogy of Fallot
: Patients with repaired tetralogy of Fallot often have pulmonary valvar regurgitation with variable degrees of right ventricular dilatation, which may lead to dysfunction of both ventricles. Therefore, some patients may need pulmonary valve replacement. This calls for adequate patient selection, and there are ventricular volumetric guidelines to aid this. However, pulmonary valve replacement has caused a dilemma because: 1- It often does not reverse right ventricular dilatation back to normal nor prevent arrhythmias. 2- It is argued that right ventricular dilatation occurs early after repair of tetralogy of Fallot but remains stable thereafter. 3- The patient’ prognosis is said to be affected mainly by the function of the left ventricle rather than that of the right ventricle. 4- Prosthetic valves on the right side of the heart are more prone to infection as compared to the left side since bacteria can reach them easily. All these concerns are examined in this Opinion Article. Overall, this dilemma is justified but usually not sufficiently elaborated and often gives the incorrect message that this procedure is of no benefit. The reality is, however, that pulmonary valvar regurgitation is a harmful condition and deserves to be remedied on hemodynamic grounds. The dilemma arises because hemodynamic improvement after valve implantation may be partial, and many think that this is not enough to justify an intervention, especially with the added risk of endocarditis. However, if valve replacement is to be offered, this should be done in a timely fashion; waiting too long is associated with a worse outcome.
- 12 April 2024
- Published by ICR Publications LTD in Journal of Heart Valve Disease Innovation
- Vol. 29 (1) , 30-36
Open AccessThe Dilemma of Pulmonary Valve Replacement In Patients With Repaired Tetralogy of Fallot
: Patients with repaired tetralogy of Fallot often have pulmonary valvar regurgitation with variable degrees of right ventricular dilatation, which may lead to dysfunction of both ventricles. Therefore, some patients may need pulmonary valve replacement. This calls for adequate patient selection, and there are ventricular volumetric guidelines to aid this. However, pulmonary valve replacement has caused a dilemma because: 1- It often does not reverse right ventricular dilatation back to normal nor prevent arrhythmias. 2- It is argued that right ventricular dilatation occurs early after repair of tetralogy of Fallot but remains stable thereafter. 3- The patient’ prognosis is said to be affected mainly by the function of the left ventricle rather than that of the right ventricle. 4- Prosthetic valves on the right side of the heart are more prone to infection as compared to the left side since bacteria can reach them easily. All these concerns are examined in this Opinion Article. Overall, this dilemma is justified but usually not sufficiently elaborated and often gives the incorrect message that this procedure is of no benefit. The reality is, however, that pulmonary valvar regurgitation is a harmful condition and deserves to be remedied on hemodynamic grounds. The dilemma arises because hemodynamic improvement after valve implantation may be partial, and many think that this is not enough to justify an intervention, especially with the added risk of endocarditis. However, if valve replacement is to be offered, this should be done in a timely fashion; waiting too long is associated with a worse outcome.
- Open Access
- 6 February 2024
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 12, 1341443
Case Report: Transcatheter interventional procedure to innominate vein turn-down procedure for failing fontan circulation
Fontan physiology creates a chronic state of decreased cardiac output and systemic venous congestion, leading to liver cirrhosis/malignancy, protein-losing enteropathy, chylothorax, or plastic bronchitis. Creating a fenestration improves cardiac output and relieves some venous congestion. The anatomic connection of the thoracic duct to the subclavian-jugular vein junction exposes the lymphatic system to systemic venous hypertension and could induce plastic bronchitis. To address this complication, two techniques have been developed. A surgical method that decompresses the thoracic duct by diverting the innominate vein to the atrium, and a percutaneous endovascular procedure that uses a covered stent to create an extravascular connection between the innominate vein and the left atrium. We report a novel variant transcatheter intervention of the innominate vein turn-down procedure without creating an extravascular connection in a 39-month-old patient with failing Fontan circulation complicated by plastic bronchitis and a 2-year post-intervention follow-up.
- 6 February 2024
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 12, 1341443
Open AccessCase Report: Transcatheter interventional procedure to innominate vein turn-down procedure for failing fontan circulation
Fontan physiology creates a chronic state of decreased cardiac output and systemic venous congestion, leading to liver cirrhosis/malignancy, protein-losing enteropathy, chylothorax, or plastic bronchitis. Creating a fenestration improves cardiac output and relieves some venous congestion. The anatomic connection of the thoracic duct to the subclavian-jugular vein junction exposes the lymphatic system to systemic venous hypertension and could induce plastic bronchitis. To address this complication, two techniques have been developed. A surgical method that decompresses the thoracic duct by diverting the innominate vein to the atrium, and a percutaneous endovascular procedure that uses a covered stent to create an extravascular connection between the innominate vein and the left atrium. We report a novel variant transcatheter intervention of the innominate vein turn-down procedure without creating an extravascular connection in a 39-month-old patient with failing Fontan circulation complicated by plastic bronchitis and a 2-year post-intervention follow-up.
- Open Access
- 10 August 2022
- Published by Elsevier in International Journal of Cardiology Congenital Heart Disease
- Vol. 10
Outcome of humanitarian patients with late complete repair of tetralogy of Fallot: A 13-year long single-center experience
- 10 August 2022
- Published by Elsevier in International Journal of Cardiology Congenital Heart Disease
- Vol. 10
Open AccessOutcome of humanitarian patients with late complete repair of tetralogy of Fallot: A 13-year long single-center experience
- Open Access
Gestational diabetes mellitus and offspring’s carotid intima–media thickness at birth: MySweetHeart Cohort study
Objective Hyperglycaemia during pregnancy is associated with cardiometabolic risks for the mother and the offspring. Mothers with gestational diabetes mellitus (GDM) have signs of subclinical atherosclerosis, including increased carotid intima–media thickness (CIMT). We assessed whether GDM is associated with increased CIMT in the offspring at birth. Design and setting MySweetHeart Cohort is a prospective cohort study conducted in Switzerland. Participants, exposure and outcome measures This work included pregnant women with and without GDM at 24–32 weeks of gestation and their singleton live-born offspring with data on the primary outcome of CIMT. GDM was diagnosed based on the criteria of the International Association of Diabetes and Pregnancy Study Groups. Offspring’s CIMT was measured by ultrasonography after birth (range 1–19 days). Results Data on CIMT were available for 99 offspring of women without GDM and 101 offspring of women with GDM. Maternal age ranged from 18 to 47 years. Some 16% of women with GDM and 6% of women without GDM were obese. Smoking during pregnancy was more frequent among women with GDM (18%) than among those without GDM (4%). Neonatal characteristics were comparable between the two groups. The difference in CIMT between offspring of women with and without GDM was of 0.00 mm (95% CI −0.01 to 0.01; p=0.96) and remained similar on adjustment for potential confounding factors, such as maternal prepregnancy body mass index, maternal education, smoking during pregnancy, family history of diabetes, as well as offspring’s sex, age, and body surface area (0.00 mm (95% CI −0.02 to 0.01; p=0.45)). Conclusions We found no evidence of increased CIMT in neonates exposed to GDM. A longer-term follow-up that includes additional vascular measures, such as endothelial function or arterial stiffness, may shed further light on the cardiovascular health trajectories in children born to mothers with GDM. Trial registration number NCT02872974; Pre-results.
Open AccessGestational diabetes mellitus and offspring’s carotid intima–media thickness at birth: MySweetHeart Cohort study
Objective Hyperglycaemia during pregnancy is associated with cardiometabolic risks for the mother and the offspring. Mothers with gestational diabetes mellitus (GDM) have signs of subclinical atherosclerosis, including increased carotid intima–media thickness (CIMT). We assessed whether GDM is associated with increased CIMT in the offspring at birth. Design and setting MySweetHeart Cohort is a prospective cohort study conducted in Switzerland. Participants, exposure and outcome measures This work included pregnant women with and without GDM at 24–32 weeks of gestation and their singleton live-born offspring with data on the primary outcome of CIMT. GDM was diagnosed based on the criteria of the International Association of Diabetes and Pregnancy Study Groups. Offspring’s CIMT was measured by ultrasonography after birth (range 1–19 days). Results Data on CIMT were available for 99 offspring of women without GDM and 101 offspring of women with GDM. Maternal age ranged from 18 to 47 years. Some 16% of women with GDM and 6% of women without GDM were obese. Smoking during pregnancy was more frequent among women with GDM (18%) than among those without GDM (4%). Neonatal characteristics were comparable between the two groups. The difference in CIMT between offspring of women with and without GDM was of 0.00 mm (95% CI −0.01 to 0.01; p=0.96) and remained similar on adjustment for potential confounding factors, such as maternal prepregnancy body mass index, maternal education, smoking during pregnancy, family history of diabetes, as well as offspring’s sex, age, and body surface area (0.00 mm (95% CI −0.02 to 0.01; p=0.45)). Conclusions We found no evidence of increased CIMT in neonates exposed to GDM. A longer-term follow-up that includes additional vascular measures, such as endothelial function or arterial stiffness, may shed further light on the cardiovascular health trajectories in children born to mothers with GDM. Trial registration number NCT02872974; Pre-results.
- Open Access
- 27 April 2022
- Published by Elsevier in International Journal of Cardiology Congenital Heart Disease
- Vol. 8
Point-of-care HEMOstasis in children with congenital heart disease, the POCHEMO study: Rotational thromboelastometry and impedance aggregometry in children with cyanotic and non-cyanotic congenital heart disease
- 27 April 2022
- Published by Elsevier in International Journal of Cardiology Congenital Heart Disease
- Vol. 8
Open AccessPoint-of-care HEMOstasis in children with congenital heart disease, the POCHEMO study: Rotational thromboelastometry and impedance aggregometry in children with cyanotic and non-cyanotic congenital heart disease